Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production - Toyonaga, J; Tsuruya, K; Ikeda, H; Noguchi, H; Yotsueda, H; Fujisaki, K; Hirakawa, M; Taniguchi, M; Masutani, K; Iida, M (Nephrol Dial Transplant, 2011)